Cabenuva ER 600 MG-900 MG susp 6ML
Ended Awarded Last action
- Contract number
- SPE2DR26FQR8Y
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $40,224
Award facts
- Contract value 100% obligated
- $40,224.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $40,224.30 delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of Cabenuva ER 600 mg-900 mg suspension (6ml units). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of January 2, 2026. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to meet competitive federal procurement requirements across multiple therapeutic domains, including specialty medications, vaccines, and medical devices. As a child contract under the DLA's broader pharmaceutical procurement strategy, this delivery order reflects AmerisourceBergen's role in supporting the Defense Health Agency and other government healthcare systems through flexible and comprehensive contract vehicles designed to ensure reliable pharmaceutical supply chains for military operations and personnel.
Quick answers
Who was awarded contract SPE2DR26FQR8Y?
SPE2DR26FQR8Y was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 10, 2025.
How much is contract SPE2DR26FQR8Y worth?
The government has obligated $40,224 on SPE2DR26FQR8Y.
Is contract SPE2DR26FQR8Y an order under another contract?
Yes. SPE2DR26FQR8Y is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQR8Y competed?
The extent of competition for SPE2DR26FQR8Y was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award